American Century Companies’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $484K | Buy |
129,668
+15,911
| +14% | +$59.3K | ﹤0.01% | 2535 |
|
|
2025
Q1 | $314K | Buy |
113,757
+532
| +0.5% | +$1.47K | ﹤0.01% | 2652 |
|
|
2024
Q4 | $627K | Buy |
113,225
+28,330
| +33% | +$157K | ﹤0.01% | 2413 |
|
|
2024
Q3 | $708K | Buy |
84,895
+20,776
| +32% | +$173K | ﹤0.01% | 2353 |
|
|
2024
Q2 | $437K | Buy |
64,119
+9,635
| +18% | +$65.6K | ﹤0.01% | 2494 |
|
|
2024
Q1 | $357K | Buy |
54,484
+26,050
| +92% | +$171K | ﹤0.01% | 2570 |
|
|
2023
Q4 | $185K | Buy |
28,434
+7,622
| +37% | +$49.5K | ﹤0.01% | 2716 |
|
|
2023
Q3 | $105K | Sell |
20,812
-42
| -0.2% | -$211 | ﹤0.01% | 2718 |
|
|
2023
Q2 | $182K | Buy |
+20,854
| New | +$182K | ﹤0.01% | 2546 |
|